Stemline Therapeutics Inc (NASDAQ:STML)

16.85
Delayed Data
As of 4:00pm ET
 +0.15 / +0.90%
Today’s Change
7.30
Today|||52-Week Range
18.75
+8.01%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Bergstein Ivan
Chief Executive Officer
Sale3/12/201831,740$17.18$545.3K-4.02%
Hoberman Kenneth
Chief Operating Officer
Sale3/12/201813,942$17.18$239.5K-4.02%
Bergstein Ivan
Chief Executive Officer
Sale2/27/201813,407$17.26$231.4K-1.76%
Hoberman Kenneth
Chief Operating Officer
Sale3/13/201812,746$16.82$214.4K-0.30%
Hoberman Kenneth
Chief Operating Officer
Sale1/08/201814,040$13.93$195.6K+20.14%
Bergstein Ivan
Chief Executive Officer
Sale2/26/201810,776$17.61$189.8K-4.84%
Hoberman Kenneth
Chief Operating Officer
Sale12/15/201711,943$14.18$169.4K+13.22%
Gionco David G
Chief Accounting Officer
Sale3/12/20187,658$17.20$131.7K-4.02%
Bergstein Ivan
Chief Executive Officer
Sale3/07/20186,797$16.56$112.6K-1.76%
Bergstein Ivan
Chief Executive Officer
Sale3/12/20186,117$18.17$111.1K-4.02%
Page of 3